Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Effects of TMS on Memory-consolidation in Human Primary Visual Cortex

This study has been withdrawn prior to enrollment.
(Due to administrative issues, the study was withdrawn.)
Information provided by:
Sheba Medical Center Identifier:
First received: May 29, 2007
Last updated: August 28, 2011
Last verified: August 2011
Rapid Transcranial Magnetic Stimulation will be used in order to examine whether the human primary visual cortex is essential to visual memory consolidation.

Condition Intervention
Device: rTMS

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Basic Science
Official Title: The Effects of Transcranial Magnetic Stimulation of the Brain on Memory-consolidation in Human Primary Visual Cortex

Resource links provided by NLM:

Further study details as provided by Sheba Medical Center:

Estimated Enrollment: 0
Study Start Date: May 2005
Estimated Primary Completion Date: June 2007 (Final data collection date for primary outcome measure)
Intervention Details:
    Device: rTMS
    repetitive transcranial meagnetic stimulation of the brain

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Healthy
  • Right handed

Exclusion Criteria:

  • Active/past neurological/psychiatric disorder
  • Personal/first-degree history of seizures
  • Cardio-vascular disorder or disease including hypertension chronic use of medication
  • Metal/electronic device implant
  • Pregnancy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00480012

Sponsors and Collaborators
Sheba Medical Center
Principal Investigator: Revital Amiaz, MD Sheba Medical Center
  More Information

Responsible Party: Amiaz Revital, MD - Senior Psychiatrist, Sheba Medical Center Identifier: NCT00480012     History of Changes
Other Study ID Numbers: SHEBA-04-3437-RA-CTIL 
Study First Received: May 29, 2007
Last Updated: August 28, 2011
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Sheba Medical Center:
healthy subjects processed this record on October 26, 2016